Latest period
$29.10M
YoY change
+27.3%
5Y CAGR
-6.9%
Peak year (2021)
$37.50M
Latest annual
$23.80M
Stock-Based Compensation history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: $23.80M
Stock-Based Compensation growth chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: +27.3%
Stock-Based Compensation history table for West Pharmaceutical Services (WST) from 1989 to 2025
| 2025 | $23.80M | +27.3% | +$5.10M | ||
| 2024 | $18.70M | -19.7% | −$4.60M | ||
| 2023 | $23.30M | -1.7% | −$400.00K | ||
| 2022 | $23.70M | -36.8% | −$13.80M | ||
| 2021 | $37.50M | +10.3% | +$3.50M | ||
| 2020 | $34.00M | +39.3% | +$9.60M | ||
| 2019 | $24.40M | +61.6% | +$9.30M | ||
| 2018 | $15.10M | -6.2% | −$1.00M | ||
| 2017 | $16.10M | -17.4% | −$3.40M | ||
| 2016 | $19.50M | -34.1% | −$10.10M | ||
| 2015 | $29.60M | +59.1% | +$11.00M | ||
| 2014 | $18.60M | -12.3% | −$2.60M | ||
| 2013 | $21.20M | +36.8% | +$5.70M | ||
| 2012 | $15.50M | +84.5% | +$7.10M | ||
| 2011 | $8.40M | +7.7% | +$600.00K | ||
| 2010 | $7.80M | +4.0% | +$300.00K | ||
| 2009 | $7.50M | +17.2% | +$1.10M | ||
| 2008 | $6.40M | — | +$6.40M | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | $0.00 | ||
| 1989 | $0.00 | — | — |
- 2025$23.80M+27.3%
- 2024$18.70M-19.7%
- 2023$23.30M-1.7%
- 2022$23.70M-36.8%
- 2021$37.50M+10.3%
- 2020$34.00M+39.3%
- 2019$24.40M+61.6%
- 2018$15.10M-6.2%
- 2017$16.10M-17.4%
- 2016$19.50M-34.1%
- 2015$29.60M+59.1%
- 2014$18.60M-12.3%
- 2013$21.20M+36.8%
- 2012$15.50M+84.5%
- 2011$8.40M+7.7%
- 2010$7.80M+4.0%
- 2009$7.50M+17.2%
- 2008$6.40M—
- 2007$0.00—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
- 1989$0.00—
Stock-Based Compensation values are taken from West Pharmaceutical Services's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at West Pharmaceutical Services (WST)
Stock-Based Compensation for West Pharmaceutical Services (WST): headline value $29.10M · YoY +27.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual stock-based compensation for West Pharmaceutical Services (WST) came in at $23.80M – grew 27.3% year-over-year.
West Pharmaceutical Services stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -6.9%, with a net decline across the window.
The record annual stock-based compensation stands at $37.50M, reached in 2021; the historical low of $0.00 was recorded in 1989.
West Pharmaceutical Services Stock-Based Compensation by Year
West Pharmaceutical Services Stock-Based Compensation 2025: $23.80M
West Pharmaceutical Services posted stock-based compensation of $23.80M in 2025, grew 27.3% from 2024.
West Pharmaceutical Services Stock-Based Compensation 2024: $18.70M
In 2024, West Pharmaceutical Services reported stock-based compensation of $18.70M, declined 19.7% below 2023.
West Pharmaceutical Services Stock-Based Compensation 2023: $23.30M
West Pharmaceutical Services stock-based compensation in 2023 was $23.30M, edged down 1.7% below 2022.
West Pharmaceutical Services Stock-Based Compensation 2022: $23.70M
2022's stock-based compensation for West Pharmaceutical Services came in at $23.70M, plunged 36.8% below 2021.
West Pharmaceutical Services Stock-Based Compensation 2021: $37.50M
West Pharmaceutical Services stock-based compensation in 2021 was $37.50M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Stock-Based Compensation
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation